Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 26159-36-4
2. (-)-2-(6-methoxy-2-naphthyl)-1-propanol
3. (-)-6-methoxy-beta-methyl-2-naphthaleneethanol
4. Rs-4034
5. (2s)-2-(6-methoxynaphthalen-2-yl)propan-1-ol
6. (s)-(-)-2-(6-methoxy-2-naphthyl)-1-propanol
7. Chebi:61022
8. Nsc-758618
9. (-)-(s)-6-methoxy-beta-methyl-2-naphthaleneethanol
10. (s)-2-(6-methoxynaphthalen-2-yl)propan-1-ol
11. 33s398gay6
12. (2s)-2-(6-methoxy-2-naphthyl)propan-1-ol
13. Naproxolum
14. Naproxol [usan:inn]
15. Unii-33s398gay6
16. Ncgc00095068-01
17. Rs 4034
18. Spectrum_001498
19. Naproxol [usan]
20. Naproxol (usan/inn)
21. Naproxol [inn]
22. Spectrum2_000494
23. Spectrum3_000973
24. Spectrum4_001097
25. Spectrum5_001281
26. Epitope Id:139984
27. Dsstox_cid_25904
28. Dsstox_rid_81216
29. Dsstox_gsid_45904
30. Schembl43203
31. Bspbio_002605
32. Kbiogr_001514
33. Kbioss_001978
34. Spectrum1503801
35. Spbio_000387
36. 2-naphthaleneethanol, 6-methoxy-.beta.-methyl-, (s)-
37. Chembl2105135
38. Dtxsid1045904
39. Kbio2_001978
40. Kbio2_004546
41. Kbio2_007114
42. Kbio3_001825
43. Hms1922g22
44. Hms2093k03
45. Pharmakon1600-01503801
46. Zinc2013137
47. Tox21_111409
48. Ccg-39576
49. Mfcd28963672
50. Nsc758618
51. Nsc 758618
52. Ncgc00178581-01
53. Sbi-0051841.p002
54. Cas-26159-36-4
55. (s)-2-(6-methoxy-naphthalen-2-yl)-propan-ol
56. D05121
57. Sr-05000002061
58. Sr-05000002061-1
59. 2-naphthaleneethanol, 6-methoxy-beta-methyl-, (s)-
60. Brd-k34014345-001-02-6
61. Q27130569
62. (-)-(s)-6-methoxy-.beta.-methyl-2-naphthaleneethanol
| Molecular Weight | 216.27 g/mol |
|---|---|
| Molecular Formula | C14H16O2 |
| XLogP3 | 3.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | 216.115029749 g/mol |
| Monoisotopic Mass | 216.115029749 g/mol |
| Topological Polar Surface Area | 29.5 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 217 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
97
PharmaCompass offers a list of Naproxol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Naproxol manufacturer or Naproxol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Naproxol manufacturer or Naproxol supplier.
PharmaCompass also assists you with knowing the Naproxol API Price utilized in the formulation of products. Naproxol API Price is not always fixed or binding as the Naproxol Price is obtained through a variety of data sources. The Naproxol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Naproxol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Naproxol, including repackagers and relabelers. The FDA regulates Naproxol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Naproxol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Naproxol supplier is an individual or a company that provides Naproxol active pharmaceutical ingredient (API) or Naproxol finished formulations upon request. The Naproxol suppliers may include Naproxol API manufacturers, exporters, distributors and traders.
click here to find a list of Naproxol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Naproxol DMF (Drug Master File) is a document detailing the whole manufacturing process of Naproxol active pharmaceutical ingredient (API) in detail. Different forms of Naproxol DMFs exist exist since differing nations have different regulations, such as Naproxol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Naproxol DMF submitted to regulatory agencies in the US is known as a USDMF. Naproxol USDMF includes data on Naproxol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Naproxol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Naproxol suppliers with USDMF on PharmaCompass.
Naproxol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Naproxol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Naproxol GMP manufacturer or Naproxol GMP API supplier for your needs.
A Naproxol CoA (Certificate of Analysis) is a formal document that attests to Naproxol's compliance with Naproxol specifications and serves as a tool for batch-level quality control.
Naproxol CoA mostly includes findings from lab analyses of a specific batch. For each Naproxol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Naproxol may be tested according to a variety of international standards, such as European Pharmacopoeia (Naproxol EP), Naproxol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Naproxol USP).
